DOSSIER · 13F Holders · Q2 2026Healthcare · Pharmaceutical Preparations
TVTX
TRAVERE THERAPEUTICS INC
305 institutions still hold TRAVERE THERAPEUTICS INC as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 89422G107·Pharmaceutical Preparations·305 13F holders·last filed Jun 30, 2026
AI Holders Summary · Q2 2026
305 institutions reported TVTX in Q2 2026. BlackRock, Inc. leads at 17.7% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.
Page 1 of 16
285 more holders available. Log in →